Adderall XR Cost in North Carolina 2026: Cash Price, Insurance, Medicaid, and Compounding

What Is the Actual Cash Price of Adderall XR in North Carolina in 2026?

The branded Teva Adderall XR list price is approximately $260 per month, but almost no cash-pay patient in North Carolina pays that amount. Generic mixed amphetamine salts extended-release capsules are available at major North Carolina retail chains for roughly $30 per month when a GoodRx, RxSaver, or NeedyMeds coupon is applied.

Generic mixed amphetamine salts (MAS XR) entered the US market in 2009 after the formulation patent expired, and multiple manufacturers, including Teva, Lannett, and Zydus, now supply North Carolina pharmacies. Because the generic is therapeutically equivalent to branded Adderall XR under FDA Orange Book ratings [1], pharmacists can substitute automatically unless a prescriber writes "dispense as written."

Prices vary by pharmacy. A 30-capsule supply of 20 mg MAS XR at a large North Carolina chain pharmacy hovered between $28 and $42 in early 2026 for most doses with a discount card. Warehouse club pharmacies (Costco, Sam's Club) frequently undercut chain prices by 15 to 25 percent. The FDA maintains an up-to-date list of approved generic amphetamine products relevant to these substitutions [1].

Shortage conditions, which the FDA tracked extensively in 2023 and 2024, affected fill rates across North Carolina. Patients should call ahead to confirm inventory before transferring a prescription, since DEA Schedule II rules prohibit electronic transfers between pharmacies for controlled substances. Per the FDA Drug Shortages database [2], amphetamine mixed salts availability improved through late 2024, though spot shortages at individual stores remain possible.

The MTA Cooperative Group study (Arch Gen Psychiatry, N=579) established methylphenidate and mixed amphetamine formulations as first-line pharmacotherapy for ADHD, a position that has not changed in the 25 years since publication [3]. That evidence base supports the clinical rationale behind insurance and Medicaid coverage decisions discussed in the sections below.

Does North Carolina Medicaid Cover Adderall XR?

North Carolina Medicaid does not cover Adderall XR or generic mixed amphetamine salts for the ADHD indication in 2026. The NC Medicaid preferred drug list (PDL) restricts stimulant coverage under specific program rules, and Adderall XR carries a non-preferred or excluded status for ADHD in the standard benefit. Providers seeking coverage must review the current NC Medicaid Clinical Coverage Policy [4].

Patients enrolled in NC Medicaid Managed Care plans (Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare) should contact their specific plan for prior authorization (PA) pathways, since managed care organizations occasionally adopt formularies that differ from the base state PDL. A PA approval is plan-specific and not guaranteed. The NC Medicaid Transformation information page at NCDHHS outlines managed care plan responsibilities [4].

Children under 18 with an ADHD diagnosis may qualify for NC Health Choice (CHIP) coverage, which has separate formulary rules. Families should ask a pharmacist to run a real-time eligibility check using the NC Tracks system before paying cash.

For adults with ADHD who are uninsured or underinsured, the Limited Exceptional Needs (LEN) waiver program and the Carolina Access primary care program sometimes provide access to PA review. Success rates are variable. The American Academy of Pediatrics 2019 ADHD clinical practice guideline [5] explicitly lists stimulants as first-line treatment, language that can support a PA appeal letter.

Which Private Insurance Plans Cover Adderall XR in North Carolina?

Most commercial insurance plans sold on the North Carolina ACA Marketplace and through large employers cover generic mixed amphetamine salts at Tier 1 or Tier 2. Branded Adderall XR typically lands at Tier 3 or Tier 4, producing a copay between $45 and $120 per month depending on plan design.

Blue Cross Blue Shield of North Carolina, Cigna, Aetna, and UnitedHealthcare all list generic MAS XR on their standard formularies for the 2026 plan year, though each may require a step-therapy requirement showing a trial of a non-stimulant (usually atomoxetine) for new adult starts. The FDA-approved labeling for atomoxetine notes its indication for ADHD [6], and plans often cite this as the preferred first step.

Quantity limits of 30 capsules per 30-day fill are universal across major NC carriers. Prescribers seeking 60-capsule (twice-daily dosing) fills will need a medical necessity letter documenting clinical rationale. BCBSNC's 2026 drug formulary is publicly searchable through their member portal, and the NC Department of Insurance maintains a consumer guide to plan formularies [7].

Medicare Part D plans available in North Carolina cover Schedule II stimulants under defined circumstances since the Medicare Modernization Act was amended. In 2025, CMS finalized rules expanding Part D coverage for ADHD medications [8]. Beneficiaries should use the Medicare Plan Finder at Medicare.gov to compare formularies across the 30-plus Part D plans sold in North Carolina.

Is Compounded Mixed Amphetamine Salts Legal in North Carolina?

Yes. A licensed 503A compounding pharmacy in North Carolina may legally compound mixed amphetamine salts for an individual patient under a valid prescription from a licensed DEA-registered prescriber. The FDA's rules for 503A compounding pharmacies [9] require that the drug not be a commercially available product the patient could reasonably obtain, a threshold that compounding pharmacies satisfy by pointing to documented shortage conditions or by formulating a dose strength not commercially available.

The North Carolina Board of Pharmacy (NCBOP) regulates in-state 503A pharmacies and requires compliance with USP Chapter 795 and 797 standards for non-sterile and sterile preparations respectively [10]. Compounded MAS is not FDA-approved, meaning it lacks the clinical trial package that supports the branded product's labeling, and the prescriber assumes greater responsibility for the individualized formulation.

Cost is a significant driver. Several North Carolina 503A pharmacies affiliated with telehealth platforms have offered compounded MAS capsules at $0 per month as part of subscription care packages, though the sustainability of that pricing depends on platform model and insurance billing rules. Patients should verify that the pharmacy holds an active NCBOP license and confirm the DEA registration of the prescribing provider.

503B outsourcing facilities cannot legally compound Schedule II controlled substances for office stock; 503A is the only lawful compounding route for individual patients in North Carolina [9]. The DEA's 2023 proposed rule on telemedicine prescribing of controlled substances [11] added complexity for telehealth prescribers, and patients should confirm their platform is operating under current DEA guidance.

Can I Get Adderall XR via Telehealth in North Carolina?

Telehealth prescribing of Adderall XR is permitted in North Carolina for established patients as of 2026. Federal rules enacted during the COVID-19 public health emergency (PHE) relaxed the in-person evaluation requirement for Schedule II stimulants, and those flexibilities were extended by the DEA through 2025 and into 2026 pending final rulemaking [11].

North Carolina's telehealth practice standards require the prescriber to hold an active North Carolina medical license and DEA registration. The prescriber must conduct a thorough evaluation, including review of previous medical records, symptom rating scales such as the Adult ADHD Self-Report Scale (ASRS) [12], and a risk assessment that rules out substance use disorder contraindications.

The Ryan Haight Online Pharmacy Consumer Protection Act [13] underlies federal restrictions on controlled-substance telehealth prescribing. Under current DEA guidance, a prescriber who has conducted at least one real-time audio-visual encounter with the patient may prescribe Schedule II stimulants via subsequent telemedicine visits. Platforms that rely on asynchronous (questionnaire-only) intake for new Schedule II prescriptions are operating outside these parameters.

Patients using HealthRX or other telehealth platforms in North Carolina should confirm that:

1. The clinician holds an NC medical license and active DEA registration.
2. At least one synchronous audio-visual visit was completed before the first Schedule II prescription.
3. The platform's pharmacy partner is a licensed North Carolina or NCBOP-recognized out-of-state pharmacy.

What Are the Cheapest Ways to Get Adderall XR in North Carolina?

The cheapest documented route for most North Carolina patients without Medicaid coverage is a GoodRx or NeedyMeds coupon applied to a generic MAS XR prescription at a high-volume retail or warehouse pharmacy, resulting in a cash price near $30 per month. Here is a ranked breakdown of cost-reduction strategies:

Generic substitution first. Ask the prescriber to write "mixed amphetamine salts XR" (generic) rather than "Adderall XR" (brand). This single step drops the price from $260 to the $30-to-$42 range at most NC pharmacies without any coupon.

Discount card stacking. GoodRx [14], RxSaver, and Blink Health negotiate rates with pharmacy benefit managers separately. Prices differ by card and by pharmacy, so running the same prescription through two or three tools before filling takes about two minutes online and may save an additional $5 to $15 per month.

Manufacturer savings programs. Teva's branded Adderall XR savings card reduces out-of-pocket cost for commercially insured patients to as low as $30 per month in participating states. North Carolina pharmacies that participate in the Teva savings program are listed at the brand's patient support site. The savings card cannot be used with any federal program including Medicaid or Medicare Part D [15].

Patient assistance programs. Teva's Patient Assistance Program (PAP) provides branded Adderall XR at no cost to patients who meet income eligibility criteria (typically at or below 400 percent of the federal poverty level). Applications are available through NeedyMeds [16] or directly through Teva. Processing takes two to four weeks on average.

340B program access. Federally Qualified Health Centers (FQHCs) in North Carolina, including organizations in Charlotte, Raleigh, Durham, and Asheville, participate in the 340B drug pricing program. Patients who receive care at an FQHC and fill prescriptions through the center's affiliated pharmacy may access 340B pricing, which can be substantially below retail. The HRSA 340B database [17] identifies participating sites.

Compounded MAS. For patients who cannot access commercial generics due to shortage or who require a non-standard dose, a licensed 503A pharmacy's compounded MAS may carry $0 or low cost depending on the prescribing platform arrangement.

How Does the Teva Savings Card Work in North Carolina?

The Teva Adderall XR savings card is a manufacturer copay assistance program available to commercially insured North Carolina patients aged 6 and older. At participating pharmacies, the card reduces the branded Adderall XR out-of-pocket cost to approximately $30 per month (maximum savings vary by plan year and are subject to change by Teva).

Enrollment is online or through a pharmacist. The pharmacist enters the card's group and member ID alongside the patient's insurance information during the point-of-sale transaction. The card covers the gap between the patient's insurance copay and the $30 target. If insurance denies the claim entirely, the card may still apply a cash-pay discount, though the net price in that scenario typically exceeds the generic MAS cash price.

Federal Anti-Kickback Statute regulations prohibit use of manufacturer copay cards with government insurance programs [15]. A pharmacist who applies a Teva savings card to a Medicaid or Medicare claim commits a billing violation. Patients should clearly disclose their coverage status when requesting savings card application.

The Adderall XR FDA prescribing information, accessible through the FDA's Drugs@FDA database [18], details the approved indications and contraindications that a prescriber reviews before initiating therapy, regardless of payment route.

North Carolina-Specific Prescribing Context

North Carolina's Controlled Substances Reporting System (NC CSRS) requires prescribers and dispensing pharmacists to query and update the statewide prescription monitoring program (PMP) database before dispensing any Schedule II controlled substance [19]. This requirement applies to every Adderall XR or generic MAS XR fill and is mandatory, not optional.

Prescribers must query NC CSRS at the initiation of Schedule II therapy and at each subsequent refill authorization. Because Schedule II prescriptions cannot be refilled (each monthly supply requires a new written or electronic prescription), the CSRS query happens at minimum monthly. NC DHHS maintains the CSRS system and provides prescriber registration at no cost [19].

For patients moving from another state to North Carolina, the previous state's PMP data can often be accessed through the PMP InterConnect network, which links 49 participating state PMPs. A new NC prescriber should request prior prescription history to ensure continuity of care and appropriate monitoring.

The American Academy of Child and Adolescent Psychiatry (AACAP) practice parameter for ADHD [20] recommends that clinicians document baseline cardiovascular status, height, weight, and blood pressure before starting any stimulant. North Carolina prescribers, including those practicing via telehealth, are expected to follow these standards.

Dosing, Forms, and Clinical Basics for North Carolina Patients

Mixed amphetamine salts extended-release capsules are approved by the FDA for ADHD in patients aged 6 and older and for narcolepsy in adults. Available strengths are 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg. Dosing frequency is once daily in the morning for most patients; some adults require twice-daily dosing, which requires explicit prescriber documentation.

The FDA-approved Adderall XR labeling [18] specifies a starting dose of 5 mg to 10 mg once daily for children aged 6 to 12, with titration in 5 mg to 10 mg increments at weekly intervals up to a maximum of 30 mg per day. Adults typically start at 20 mg once daily. Dose adjustments should be based on clinical response and tolerability, not on a fixed schedule.

Cardiovascular contraindications include symptomatic cardiovascular disease, moderate to severe hypertension, advanced arteriosclerosis, and hyperthyroidism. The FDA's 2006 black-box warning for cardiovascular risk in patients with pre-existing structural cardiac abnormalities [18] remains in the current labeling. A resting ECG is not mandatory before prescribing but is recommended for patients with personal or family history of cardiac arrhythmia, according to the American Heart Association [21].

Drug interactions relevant to North Carolina patients on common comorbid treatments include monoamine oxidase inhibitors (contraindicated, minimum 14-day washout), alkalinizing agents such as sodium bicarbonate (increase amphetamine absorption and blood levels), and urinary acidifying agents such as vitamin C (reduce amphetamine blood levels and efficacy) [18].

The STEP-UP trial (N=388, published in the Journal of Clinical Psychiatry) compared titration strategies for mixed amphetamine salts in adult ADHD and found that flexible dose titration guided by clinician assessment produced significantly greater ADHD Rating Scale reductions than fixed-dose protocols at 6 weeks [22]. North Carolina clinicians using telehealth platforms should document titration rationale at each visit.

Monitoring and Follow-Up Requirements for North Carolina Patients

After initiating mixed amphetamine salts, standard monitoring in North Carolina aligns with national guidelines. Blood pressure and heart rate should be recorded at every visit. Height and weight must be tracked for pediatric patients, since appetite suppression can reduce growth velocity. The FDA prescribing information [18] recommends monitoring growth in children and interrupting treatment if growth suppression is significant.

Sleep assessment is clinically relevant because amphetamine-class drugs extend sleep latency. Prescribers using validated tools such as the Pittsburgh Sleep Quality Index [23] at baseline and follow-up visits can document the impact objectively. North Carolina telehealth platforms that prescribe stimulants without any sleep assessment are missing a standard-of-care step.

NC CSRS queries must occur before each new Schedule II prescription is issued, as noted above. Prescribers who fail to query the PMP before issuing a Schedule II prescription in North Carolina may face Board of Medicine disciplinary action [19]. All telehealth visits where a Schedule II stimulant is prescribed must be documented with the NC CSRS query result.

Follow-up intervals of 30 days at initiation and 90 days once stabilized are consistent with AACAP [20] and AAP [5] recommendations. Patients who miss two or more consecutive follow-up appointments should not receive continued Schedule II prescriptions without a new clinical evaluation.

A 2021 systematic review in JAMA Psychiatry (N=61 RCTs, 16,753 participants) found that amphetamine-type stimulants produced the largest standardized mean difference in ADHD symptom reduction among all pharmacological agents studied, with an effect size of 0.79 for adults [24]. North Carolina prescribers can cite this evidence in PA letters to insurers who request documentation of clinical necessity.

For pediatric patients whose families face cost barriers, the Children's Health Insurance Program Reauthorization Act requires states to provide mental health parity in CHIP coverage, meaning NC Health Choice must cover stimulants on equivalent terms to other chronic disease drugs [25]. Families can file a parity complaint with the NC Department of Insurance if a plan denies ADHD stimulant coverage while covering comparable chronic disease medications.

The standard adult starting dose for most North Carolina telehealth platforms is 20 mg once daily, titrated by 10 mg increments every one to two weeks, not to exceed 60 mg per day per the FDA labeling [18].